Filtered By:
Management: WHO
Vaccination: Covid Vaccine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 776 results found since Jan 2013.
Increasing SARS-CoV-2 seroprevalence among UK pediatric patients on dialysis and kidney transplantation between January 2020 and August 2021
ConclusionsAnti-SARS-CoV-2 seroprevalence was low in 2020 and increased in early 2021. Serological surveillance complements nucleic acid detection and antigen testing to build a greater picture of the epidemiology of COVID-19 and is therefore important to guide public health responses.Graphical abstractA higher resolution version of the Graphical abstract is available asSupplementary information
Source: Pediatric Nephrology - September 22, 2023 Category: Urology & Nephrology Source Type: research
Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment
Arch Med Sci. 2021 Oct 15;19(5):1410-1420. doi: 10.5114/aoms/142103. eCollection 2023.ABSTRACTCoronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), declared a global pandemic by the World Health Organization (WHO). The three key principles in management of the COVID-19 pandemic are prevention, early detection and targeted treatment. Vaccine-based prevention together with early detection has already proven its efficacy in controlling the pandemic. Early detection of infected patients could substantially accelerate the implementation of treatment,...
Source: Archives of Medical Science - September 21, 2023 Category: Biomedical Science Authors: Aleksandra Skwarek Aleksandra G ąsecka Mi łosz J Jaguszewski Łukasz Szarpak Tomasz Dzieci ątkowski Krzysztof J Filipiak Source Type: research
A study on the effect of natural products against the transmission of B.1.1.529 Omicron
The recent outbreak of the Coronavirus pandemic resulted in a successful vaccination program launched by the World Health Organization. However, a large population is still unvaccinated, leading to the emergen...
Source: Virology Journal - August 25, 2023 Category: Virology Authors: Samar Sami Alkafaas, Abanoub Mosaad Abdallah, Aya Misbah Hussien, Heba Bedair, Mahmoud Abdo, Soumya Ghosh, Sara Samy Elkafas, Wilgince Apollon, Morteza Saki, Samah A. Loutfy, Helen Onyeaka and Mohamed Hessien Tags: Review Source Type: research
Chronicling the 3-year evolution of the COVID-19 pandemic: analysis of disease management, characteristics of major variants, and impacts on pathogenicity
AbstractAnnounced on December 31, 2019, the novel coronavirus arising in Wuhan City, Hubei Province resulted in millions of cases and lives lost. Following intense tracking, coronavirus disease 2019 (COVID-19) was declared a pandemic by the World Health Organization (WHO) in 2020. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified as the cause of COVID-19 and the continuous evolution of the virus has given rise to several variants. In this review, a comprehensive analysis of the response to the pandemic over the first three-year period is provided, focusing on disease management, development of vac...
Source: Clinical and Experimental Medicine - August 24, 2023 Category: Research Source Type: research
A comprehensive review on the global efforts on vaccines and repurposed drugs for combating COVID-19
Eur J Med Chem. 2023 Aug 10;260:115719. doi: 10.1016/j.ejmech.2023.115719. Online ahead of print.ABSTRACTThe recently discovered coronavirus, known as SARS-CoV-2, is a highly contagious and potentially lethal viral infection that was declared a pandemic by the World Health Organization on March 11, 2020. Since the beginning of the pandemic, an unprecedented number of COVID-19 vaccine candidates have been investigated for their potential to manage the pandemic. Herein, we reviewed vaccine development and the associated research effort, both traditional and forward-looking, to demonstrate the advantages and disadvantages of ...
Source: European Journal of Medicinal Chemistry - August 19, 2023 Category: Chemistry Authors: Narva Deshwar Kushwaha Jivanka Mohan Babita Kushwaha Terisha Ghazi Joshua C Nwabuife Neil Koorbanally Anil A Chuturgoon Source Type: research
Can a WHO pandemic treaty help poorer nations in future outbreaks?
Global accord aims to avoid the damage caused during Covid-19 and ensure vaccines and medical equipment are distributed equally to allCovid-19 caught the world unprepared; the scramble it prompted for treatments, tests, protective equipment and vaccines favoured the world ’s richest nations. To avoid the same thing happening in future pandemics, a group of world leaders has proposed a pandemic treaty, which is being negotiated in a series of international meetings hosted by the World Health Organization (WHO).The draft treaty is aimed at ensuring equity in distributing all that is needed to handle a future pandemic, inst...
Source: Guardian Unlimited Science - August 10, 2023 Category: Science Authors: Kaamil Ahmed Tags: Global health Global development Coronavirus Infectious diseases Science World news World Health Organization Society Pharmaceuticals industry Business Source Type: news
IJERPH, Vol. 20, Pages 6526: The Relationship between Socio-Demographic Factors, Preventive Health Behaviors and Acceptance of COVID-19 Vaccine among Israeli Pregnant Women during the Coronavirus Pandemic
Conclusions: These findings can be helpful as a preliminary evidence base for policy-making at present and for future epidemics regarding guidelines on PHB adjusted for pregnant women.
Source: International Journal of Environmental Research and Public Health - August 4, 2023 Category: Environmental Health Authors: Shir Nahum Talma Kushnir Tags: Article Source Type: research
Exclusion of pregnant people from emergency vaccine clinical trials: A systematic review of clinical trial protocols and reporting from 2009 to 2019
CONCLUSION: Pregnant people are underrepresented in vaccine clinical trials conducted during outbreaks, resulting in underreporting of pregnancy-related outcomes and a lack of protection for pregnant people and neonates from infectious diseases.PMID:37442686 | DOI:10.1016/j.vaccine.2023.06.073
Source: Vaccine - July 13, 2023 Category: Allergy & Immunology Authors: Jamie Minchin Gavin H Harris Sasha Baumann Emily R Smith Source Type: research
Vaccination against coronavirus disease 2019 in patients with pulmonary hypertension: a national prospective cohort study
CONCLUSIONS: COVID-19 vaccination did not significantly augment the PH-related major adverse events for patients with WHO groups 1 and 4 PH, although there were some tolerable side effects. A large-scale randomized controlled trial is warranted to confirm this finding. The final approval of the COVID-19 vaccination for patients with PH as a public health strategy is promising.PMID:37439342 | DOI:10.1097/CM9.0000000000002767
Source: Chinese Medical Journal - July 13, 2023 Category: General Medicine Authors: Xiaohan Wu Jingyi Li Jieling Ma Qianqian Liu Lan Wang Yongjian Zhu Yue Cui Anyi Wang Cenjin Wen Luhong Qiu Yinjian Yang Dan Lu Xiqi Xu Xijie Zhu Chunyan Cheng Duolao Wang Zhicheng Jing Source Type: research
Exclusion of pregnant people from emergency vaccine clinical trials: A systematic review of clinical trial protocols and reporting from 2009 to 2019
CONCLUSION: Pregnant people are underrepresented in vaccine clinical trials conducted during outbreaks, resulting in underreporting of pregnancy-related outcomes and a lack of protection for pregnant people and neonates from infectious diseases.PMID:37442686 | DOI:10.1016/j.vaccine.2023.06.073
Source: Vaccine - July 13, 2023 Category: Allergy & Immunology Authors: Jamie Minchin Gavin H Harris Sasha Baumann Emily R Smith Source Type: research
Vaccination against coronavirus disease 2019 in patients with pulmonary hypertension: a national prospective cohort study
CONCLUSIONS: COVID-19 vaccination did not significantly augment the PH-related major adverse events for patients with WHO groups 1 and 4 PH, although there were some tolerable side effects. A large-scale randomized controlled trial is warranted to confirm this finding. The final approval of the COVID-19 vaccination for patients with PH as a public health strategy is promising.PMID:37439342 | DOI:10.1097/CM9.0000000000002767
Source: Chinese Medical Journal - July 13, 2023 Category: General Medicine Authors: Xiaohan Wu Jingyi Li Jieling Ma Qianqian Liu Lan Wang Yongjian Zhu Yue Cui Anyi Wang Cenjin Wen Luhong Qiu Yinjian Yang Dan Lu Xiqi Xu Xijie Zhu Chunyan Cheng Duolao Wang Zhicheng Jing Source Type: research
